In selection criteria based on morphokinetic analysis, it has been proposed that an embryo ought to show a certain kinetic division in order to be considered normal (types A and B, in line with ASEBIR criteria). But what happens when an embryo does not fulfil this criteria due to accelerated embryonic development with over 10 cells on day 3?
IB Biotech, the biotechnology and genetics company which is part of the Instituto Bernabeu group, has launched a renewed version of its website, www.ibbiotech.com. The webpage is an alternative means of bringing investigation on genetics closer to society as a whole through intuitive browsing which is accessible from any device.
The Ministry of Economy and Competitiveness has awarded Instituto Bernabeu the title of Innovative Company which is given to companies with a proven track record in innovation and in their ability to be innovative in R&D work.
Merci de votre intérêt à notre institution. Nous vous contacterons dans les plus brefs délais pour confirmer votre demande.
Si vous le préférez, appelez-nous :
+34 965 50 40 00